Clay Northam Wealth Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,116
Closed -$441K 85
2022
Q1
$441K Sell
6,116
-296
-5% -$21.3K 0.45% 48
2021
Q4
$589K Buy
+6,412
New +$766K 0.55% 39

Other funds holding TDOC

Clay Northam Wealth Management's TDOC Position: Q2 2022 in Review

Clay Northam Wealth Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 6,116 shares — an estimated $441K sold.

Clay Northam Wealth Management first reported a position in TDOC in Q4 2021 and held it in 2 quarters. The position peaked at $589K in Q4 2021. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Clay Northam Wealth Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Clay Northam Wealth Management sold 6,116 Teladoc Health shares in Q2 2022, an estimated $441K.
  • Clay Northam Wealth Management first reported a position in Teladoc Health in Q4 2021 and held it in 2 quarters.
  • Clay Northam Wealth Management's Teladoc Health position peaked at $589K in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Clay Northam Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.